David Burt Email Address

Senior Director Head of Biostatistics

Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in dermatology. Our lead drug candidate A-101 is being developed as an in-office treatment for seborrheic keratosis (SK), a common non-cancerous skin tumor, as well as for other cutaneous indications, such as common warts. In September 2015, Aclaris acquired a portfolio of oral and topical Janus Kinase (JAK) inhibitor compounds for the treatment of alopecia areata and other dermatological conditions. Aclaris is led by a management team with rich experience and expertise in dermatology and dermatological drug development.

Desire to gain more leadership responsibility in pharmaceutical biostatistics while maintaining technical expertise in the areas of adaptive designs, Bayesian applications, clinical trial simulation, pharmacokinetic/pharmacodynamic modeling, and biomarker development and validation. Specialties: Leader: Eighteen years experience in the industry. Familiarity with drug development. Experience with regulatory submissions. Technical leader. Decision Maker: Responsible for the quantification of development plan decisions. Extensive experience with study related decisions. Teacher: Good listener. Strong technical expertise in cutting edge methodologies. Excellent presentation skills. Able to explain more complicated analytical concepts in an easily understood manner.